Quantitative analysis for GSK plc (GSK) — Health Care: AI-powered alpha score, Benjamin Graham intrinsic value, ML-based forecast, technical and fundamental signals, and insider activity.
Current Q-Score verdict: Sell (39.0) (grade D). 40 signals analyzed (35 differentiated alt-data).
GSK stock price is tracked daily for technical and fundamental analysis. The data below shows recent trading activity used in trend analysis, momentum calculation, and entry/exit signals.
| Date | High | Low | Close |
|---|---|---|---|
| 2026-04-29 | $52.13 | $49.99 | $51.40 |
| 2026-05-11 | $50.92 | $49.71 | $49.81 |
| 2026-05-21 | $51.77 | $50.59 | $51.53 |
| 2026-06-03 | $49.89 | $49.39 | $49.72 |
| 2026-06-15 | $53.21 | $52.17 | $52.23 |
| 2026-06-26 | $52.72 | $51.62 | $52.50 |
| 2026-07-09 | $52.85 | $52.30 | $52.47 |
| 2026-07-21 | $51.31 | $50.16 | $50.78 |
| 2026-07-31 | $51.97 | $51.38 | $51.69 |
| 2026-08-12 | $50.46 | $49.86 | $50.30 |
| 2026-08-24 | $51.95 | $51.40 | $51.78 |
| 2026-09-03 | $51.52 | $50.19 | $50.87 |
How GSK plc stacks up against same-sector peers on market capitalization and alpha scores:
| Ticker | Company | Market Cap | Alpha Score |
|---|---|---|---|
| SNY | Sanofi | $107.6B | — |
| TAK | Takeda Pharmaceutical Company Limited | $52.7B | — |
| NVO | Novo Nordisk A/S | $200.3B | — |
| ARGX | argenx SE | $49.8B | — |
View all Health Care stocks by valuation and signals →
GSK plc (GSK) scores Sell (39.0), with every measured dimension at or below 29. The weakest are technicals at 29, analyst consensus at 23, across 2 measured dimensions. See Q-Score methodology for how these dimensions are weighted and combined.
| Dimension | Score |
|---|---|
| technicals | 29 |
| analyst consensus | 23 |
StoQuant analyzes 40 signals (35 alt-data). Alternative data sources (FDA approvals, GitHub activity, SEC filings, App Store ratings) complement traditional financial metrics.
All StoQuant signals are explained in our knowledge base:
Health Care Hub — Top performers and valuation outliers in Health Care
Get daily updates on GSK plc (GSK): Q-Score changes, insider transactions, forecast shifts, sector rotation, and macroeconomic context. The StoQuant digest curates the most material signals for your watchlist — free, no account required.
See a sample digest • Unsubscribe anytime • Privacy policy
StoQuant is a quantitative stock research platform powered by AI scoring, fundamental analysis, and institutional-grade signals. We cover 3,600+ US-listed equities with daily updates on valuations, earnings quality, insider flow, and ML-based return forecasts. Learn more about us.
Share this stock's latest Q-Score and alpha score on your website, GitHub README, or blog. The SVG badge auto-updates daily:
<a href="https://stoquant.com/research/GSK"><img src="https://stoquant.com/badge/GSK.svg" alt="GSK plc (GSK) Q-Score and Alpha on StoQuant" width="240" height="64" /></a>
StoQuant research is generated algorithmically using public market data, SEC filings, news feeds, and proprietary ML models. Not investment advice. Past performance does not guarantee future results.
Weekly Q-Score signals and insider buying activity on our highest-conviction stock picks. Email only, no account needed. See a sample digest.